Olfr476 Inhibitors
Olfr476, a pivotal member of the olfactory receptor family, plays a fundamental role in the intricate process of olfactory signal transduction within the nasal cavity. As a G-protein-coupled receptor (GPCR) characterized by a 7-transmembrane domain structure, Olfr476 shares structural similarities with neurotransmitter and hormone receptors. Its primary function revolves around the recognition and transduction of odorant signals, contributing significantly to the intricate world of olfactory experiences. Within the vast family of olfactory receptors, Olfr476 stands out for its involvement in initiating a neuronal response that triggers the perception of diverse smells. The receptor is integral to the complex interplay of molecular events that allow organisms to interpret and respond to their olfactory environment.
The inhibition of Olfr476 involves intricate and strategic modulation of specific cellular pathways crucial for olfactory signal transduction. These pathways include muscarinic receptor activity, JNK and PI3K-dependent events, MEK-mediated MAPK pathway, CaMKII and PKA activities, ryanodine receptor function, vesicle trafficking, and PKC-dependent processes. Inhibition disrupts the receptor's ability to initiate a neuronal response, leading to a compromised perception of odors. The nuanced interplay between various inhibitors and their respective pathways highlights the complexity of the olfactory system. Disrupting these crucial cellular processes, whether through direct or indirect means, impairs Olfr476's ability to transduce odorant signals effectively, resulting in a diminished capacity to perceive and respond to smells. The multifaceted nature of Olfr476 and its inhibition underscores the importance of understanding the intricate molecular mechanisms that underlie olfactory signal processing in organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Scopolamine | 51-34-3 | sc-473216 sc-473216A sc-473216B | 100 mg 500 mg 1 g | $172.00 $506.00 $786.00 | 2 | |
Scopolamine, a muscarinic acetylcholine receptor antagonist, directly inhibits Olfr476 by binding to muscarinic receptors. This disrupts G protein-mediated signal transduction, hindering the recognition and transduction of odorant signals within the olfactory system. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), SP600125 indirectly inhibits Olfr476 by disrupting the JNK signaling pathway. This interference impacts G protein-mediated transduction of odorant signals, altering the receptor's ability to initiate a neuronal response and perceive odors effectively. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a phosphoinositide 3-kinase (PI3K) inhibitor, directly influences intracellular signaling pathways crucial for Olfr476 function. By disrupting PI3K-dependent events, this chemical inhibits Olfr476, impairing the normal transduction of odorant signals and negatively impacting G protein-mediated responses of the olfactory receptor. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective MEK inhibitor, U0126 disrupts the MAPK pathway. This compound indirectly inhibits Olfr476 by interfering with MAPK-dependent events, negatively impacting G protein-mediated transduction of odorant signals. The disruption occurs at the level of MEK, influencing downstream events crucial for olfactory perception. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinase (PI3K) inhibitor, LY294002 influences intracellular signaling pathways crucial for Olfr476 function. By disrupting PI3K-dependent events, this chemical indirectly inhibits Olfr476, impairing the normal transduction of odorant signals and negatively impacting G protein-mediated responses of the olfactory receptor. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
A CaMKII inhibitor, KN-93 modulates CaMKII-dependent processes in olfactory signal transduction. This chemical indirectly inhibits Olfr476 by interfering with calcium-calmodulin-dependent kinase II (CaMKII), disrupting downstream events crucial for G protein-mediated transduction of odorant signals. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 mitogen-activated protein kinase (MAPK), SB-203580 indirectly inhibits Olfr476 by disrupting the p38 MAPK pathway. This disruption negatively impacts G protein-mediated transduction of odorant signals, altering the receptor's ability to initiate a neuronal response and perceive odors effectively. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene, a ryanodine receptor antagonist, indirectly inhibits Olfr476 by disrupting calcium-dependent processes. This disruption affects the intracellular calcium levels crucial for olfactory signal transduction, impairing the recognition and transduction of odorant signals by Olfr476 within the nasal cavity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of vesicle trafficking, Brefeldin A disrupts Golgi apparatus function and indirectly inhibits Olfr476. This disruption affects the proper localization and functioning of olfactory receptors, impairing the recognition and transduction of odorant signals within the nasal cavity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059, a selective MEK inhibitor, disrupts the MAPK pathway. This compound indirectly inhibits Olfr476 by interfering with MAPK-dependent events, negatively impacting G protein-mediated transduction of odorant signals. The disruption occurs at the level of MEK, influencing downstream events crucial for olfactory perception. | ||||||